Abstract
RNA recognition motif (RRM) is the most abundant RNA-binding domain, mainly known to involve in regulating post-transcriptional processes like intron splicing, stability and mRNA intracellular translocation. As RNA metabolism in neurons attributes a significant proportionality towards neurodegenerative diseases, potential role of RRM domains has become more conspicuous. Here, through flexible protein-protein docking and molecular dynamics simulation approaches, we postulate biochemically auspicious interactions occurring between Butyrylcholinesterase (BuChE) and RRM domains of transactive response DNA binding protein, embryonic lethal abnormal vision like protein 4 and heterogeneous nuclear ribonucleoprotein A1 protein. Through a comprehensive analysis of these interactions, we observed an exclusive binding behavior for RRM domains. Evidently, upon binding to RRMs, omega loop of BuChE attains a closed conformation and masks the access of substrate to the catalytic triad and oxyanion hole. Moreover, prominent adjustments were detected in RRM-bound BuChE at the peripheral anionic, choline binding and proton transfer sites. We propose that interaction of RNA-binding proteins to BuChE may decrease its ability to hydrolyze multiple choline esters, which may contribute in delayed progression of poor cognition during neurodegenerative disorders.
Keywords: Cholinergic molecular dynamic simulations, Neurodegeneration, neurotransmission, protein-protein docking, RNA recognition motif.
CNS & Neurological Disorders - Drug Targets
Title:Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins
Volume: 13 Issue: 8
Author(s): Iqra Sohail and Sajid Rashid
Affiliation:
Keywords: Cholinergic molecular dynamic simulations, Neurodegeneration, neurotransmission, protein-protein docking, RNA recognition motif.
Abstract: RNA recognition motif (RRM) is the most abundant RNA-binding domain, mainly known to involve in regulating post-transcriptional processes like intron splicing, stability and mRNA intracellular translocation. As RNA metabolism in neurons attributes a significant proportionality towards neurodegenerative diseases, potential role of RRM domains has become more conspicuous. Here, through flexible protein-protein docking and molecular dynamics simulation approaches, we postulate biochemically auspicious interactions occurring between Butyrylcholinesterase (BuChE) and RRM domains of transactive response DNA binding protein, embryonic lethal abnormal vision like protein 4 and heterogeneous nuclear ribonucleoprotein A1 protein. Through a comprehensive analysis of these interactions, we observed an exclusive binding behavior for RRM domains. Evidently, upon binding to RRMs, omega loop of BuChE attains a closed conformation and masks the access of substrate to the catalytic triad and oxyanion hole. Moreover, prominent adjustments were detected in RRM-bound BuChE at the peripheral anionic, choline binding and proton transfer sites. We propose that interaction of RNA-binding proteins to BuChE may decrease its ability to hydrolyze multiple choline esters, which may contribute in delayed progression of poor cognition during neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Sohail Iqra and Rashid Sajid, Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins, CNS & Neurological Disorders - Drug Targets 2014; 13 (8) . https://dx.doi.org/10.2174/1871527313666141023144523
DOI https://dx.doi.org/10.2174/1871527313666141023144523 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Heart and Brain Axis Targets in CNS Neurological Disorders
Recently there has been a surge of interest in delving deeper into the complex interplay between the heart and brain. This fascination stems from a growing recognition of the profound influence each organ holds over the other, particularly in the realm of central nervous system (CNS) neurological disorders. The purpose ...read more
Lifestyle Interventions to Prevent and Treat Cognitive Impairment and Dementia
More than 55 million people live with dementia worldwide. By 2050, the population affected by dementia will exceed 139 million individuals. Mild cognitive impairment (MCI) is a pre-dementia stage, also known as prodromal dementia, affecting older adults. MCI emerges years before the manifestation of dementia but can be avoidable and ...read more
Pathogenic Proteins in Neurodegenerative Diseases: From Mechanisms to Treatment Modalities
The primary objective of this thematic issue is to elucidate the molecular mechanisms by which pathogenic proteins contribute to neurodegenerative diseases and to highlight current and emerging therapeutic strategies aimed at mitigating their effects. By bringing together cutting-edge research and reviews, this issue aims to: 1.Enhance Understanding: Provide a comprehensive ...read more
Role of glial cells in autism spectrum disorder: Molecular mechanism and therapeutic approaches
Emerging evidence suggests that glial cells may play a pivotal role in neuroanatomical and behavioral changes found in autism spectrum disorder (ASD). Many individuals with ASD experience a neuro-immune system abnormalities throughout life, which implicates a potential role of microglia in the pathogenesis of ASD. Dysfunctional astrocytes and oligodendrocytes were ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory
Current Medicinal Chemistry Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer’s Disease
Current Neurovascular Research Ramalin: A Multi-Mechanistic Lichen Metabolite of Pharmacological Importance
Current Bioactive Compounds Therapeutic Trials in Human Transmissible Spongiform Encephalopathies: Recent Advances and Problems to Address
Infectious Disorders - Drug Targets An Overview of the Neuropharmacological Potential of Thymoquinone and its Targeted Delivery Prospects for CNS Disorder
Current Drug Metabolism Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides
Current Drug Targets Editorial [Hot Topic: Status of Tyrosine Hydroxylase in the Healthy and Parkinson's Brain (Guest Editor: Mohammad Amjad Kamal)]
CNS & Neurological Disorders - Drug Targets W-F Substitutions in Apomyoglobin Increase the Local Flexibility of the N-terminal Region Causing Amyloid Aggregation: A H/D Exchange Study
Protein & Peptide Letters Editorial - The As and Ms of Alzheimers Disease
Current Alzheimer Research Metal-Score as a Potential Non-Invasive Diagnostic Test for Alzheimer’s Disease
Current Alzheimer Research Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Current Drug Targets The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design One-pot Synthesis of Dihydropyrano[2,3-c]chromenes via a Three-component Reaction in Aqueous Media
Combinatorial Chemistry & High Throughput Screening The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
Current Gene Therapy Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Peptide Nucleic Acids with a Structurally Biased Backbone. Updated Review and Emerging Challenges
Current Topics in Medicinal Chemistry Anti-Alzheimer’s Materials Isolated from Marine Bio-resources: A Review
Current Alzheimer Research